Aldara contains Imiquimod as its active component. Imiquimod belongs to the skin-care therapeutic class and is marketed as a 5 % topical formulation packaged in single-use sachets. In Hong Kong, Aldara is a prescription-only medication regulated by the Pharmacy and Poisons Board (PPB) under the Department of Health. It is intended for short-term application to specific skin lesions under the supervision of a qualified healthcare professional.
Imiquimod is an immune-response modifier. When applied to the skin, it binds to toll-like receptor 7 (TLR-7) on immune cells such as dendritic cells and macrophages. This activation triggers the release of cytokines-including interferon-α, tumor-necrosis factor-α, and interleukins-which create a localized immune response. The heightened immune activity leads to the destruction of abnormal skin cells and the clearance of viral infections within the treated area.
Key pharmacologic points:
Aldara is approved in Hong Kong for the following indications:
These uses are based on clinical trials that demonstrated lesion clearance rates superior to placebo when Imiquimod 5 % was applied according to approved regimens.
Small studies and case series have reported successful clearance of molluscum contagiosum lesions with Imiquimod 5 % applied three times weekly for up to 12 weeks. Although not approved by the Hong Kong PPB for this condition, the evidence suggests potential benefit.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Limited clinical data indicate that Imiquimod may aggravate or trigger CLE lesions in susceptible individuals. Consequently, its use is not recommended for patients with a history of CLE.
These reactions are generally mild to moderate and tend to diminish with continued use or by adjusting the dosing schedule.
Imiquimod is applied topically, and systemic absorption is minimal; therefore, clinically significant drug-drug interactions are rare. However:
Patients should inform their healthcare provider of all concurrent medications, including over-the-counter products and herbal supplements.
Each sachet contains a pre-measured amount of cream; apply to clean, dry skin and allow it to dry for at least 30 minutes before covering with clothing or a bandage.
If a scheduled dose is missed, do not double the next application. Simply resume the regular dosing schedule.
Signs of excessive systemic absorption may include high fever, severe fatigue, or extensive skin irritation. In such cases, discontinue Aldara immediately and seek medical evaluation. There is no specific antidote; management is supportive.
Aldara should be stopped after the prescribed course, even if lesions have not completely resolved. Persistent lesions require evaluation for alternative therapies. Abrupt cessation does not typically cause withdrawal symptoms.
This article provides educational information about Aldara and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
If redness or pain intensifies beyond mild irritation, pause treatment for at least 48 hours and apply a gentle moisturiser. If the reaction does not improve or shows signs of infection (pus, swelling), seek medical assessment promptly.
Yes, for actinic keratosis on the face, Aldara may be applied following the prescribed schedule. Because facial skin is more sensitive, monitor for irritation and discuss any concerns with your clinician.
Concurrent use of other topical agents, especially corticosteroids, can reduce Imiquimod’s effectiveness. Apply Aldara alone, and wait at least 30 minutes before applying any non-interfering moisturiser if needed.
Visible reduction of genital warts typically begins after 4-8 weeks of consistent use, though the full course may extend to 16 weeks depending on lesion size and number.
Imiquimod’s systemic absorption is minimal, so it generally does not interfere with routine blood tests. However, inflammatory markers may be transiently elevated during active treatment.
Aldara is a prescription medication; carry the original prescription label and a copy of the prescribing information. Check the destination country’s import regulations for topical medicines.
Both deliver the same concentration of Imiquimod (5 %). Sachets provide a single-use, pre-measured dose that helps maintain dosing accuracy and reduces waste, while cream tubes allow multiple uses from a larger container.
Coverage varies by private insurance plan and public subsidy programs. Verify with your insurer or the Hospital Authority to determine eligibility for reimbursement.
Yes, the medication can be applied to separate lesions on different individuals, provided each person follows the appropriate dosing schedule and avoids cross-contamination.
Discard unused sachets according to the Hong Kong Pharmacy and Poisons Board guidelines for medication waste, typically by placing them in a household trash bag sealed to prevent accidental ingestion.
